TRVN Insider Trading

Insider Ownership Percentage: 2.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Trevena Insider Trading History Chart

This chart shows the insider buying and selling history at Trevena by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$10k-$5k$0$5k$10kTotal Insider BuyingTotal Insider Selling

Trevena Share Price & Price History

Current Price: $1.22
Price Change: Price Decrease of -0.0025 (-0.20%)
As of 04/1/2025 02:32 PM ET

This chart shows the closing price history over time for TRVN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$1.22Closing price on 03/31/25:

Trevena Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Trevena (NASDAQ:TRVN)

13.56% of Trevena stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TRVN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$1M-$500k$0$500k$1MTotal InflowsTotal Outflows
Trevena logo
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is based in Chesterbrook, Pennsylvania.
Read More on Trevena

Today's Range

Now: $1.22
Low: $1.22
High: $1.22

50 Day Range

MA: $1.59
Low: $1.22
High: $1.86

52 Week Range

Now: $1.22
Low: $1.13
High: $11.50

Volume

405 shs

Average Volume

2,564 shs

Market Capitalization

$1.05 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.05